Subscribe to MDT Magazine News

Installation of Next Generation Proton Therapy System Progressing Rapidly

October 26, 2010 9:34 am | by Bio-Medicine.Org | Comments

LITTLETON, Mass., Oct. 26 /- Still River Systems' groundbreaking proton therapy system is entering the final phase of installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO, a National Cancer Institute (NCI)...


Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study

October 26, 2010 9:33 am | by Bio-Medicine.Org | Comments

HAMILTON, N.J. and ROCKVILLE, Md., Oct. 26 /- MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN ) a clinical stage pharmaceutical company developing and commercializing potential best in...


Siemens Wins $25 Million Contract From Rush University Medical Center

October 26, 2010 9:33 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., Oct. 26 /- Rush University Medical Center in Chicago, one of the top academic medical centers in the United States, has awarded a five-year, $25 million contract for medical equipment and health IT consulting services to Siemens Medical Solutions USA, Inc. With the addition...


Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention

October 26, 2010 9:32 am | by Bio-Medicine.Org | Comments

BETHLEHEM, Pa., Oct. 26 /- A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early...


Gentiva® Health Services to Present at the Oppenheimer and Credit Suisse Healthcare Conferences

October 26, 2010 7:35 am | by Bio-Medicine.Org | Comments

ATLANTA, Oct. 26 /-Gentiva Health Services, Inc. (Nasdaq: GTIV ), the nation's largest provider of home health and hospice services, announced today that it will present at the Oppenheimer 21st Annual Healthcare Conference in New York at 2:10 p.m. ET on Tuesday, November 2, 2010 and the...


ARIAD reports positive test results, plans stock offering

October 26, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | Comments

ARIAD Pharmaceuticals Inc. has announced a stock offering to help fund tests on a treatment for chronic myeloid leukemia, while also reporting that a Phase 2 study of its treatment for endometrial cancer showed significant improvements in progression-free survival.

Intermittent Catheter Market Currently Valued at $230 Million and Set to Double by 2014

October 26, 2010 6:34 am | by Bio-Medicine.Org | Comments

TORONTO, Oct. 26 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, reimbursement changes have caused the demand for intermittent catheters to increase significantly. In April 2008, Medicare changed reimbursement to cover up to...


Next Intelligence Health Expands US Channel Program

October 26, 2010 6:34 am | by Bio-Medicine.Org | Comments

WILMINGTON, Del., Oct. 26 /- Next Intelligence Corporation ( ), the leader in message-based nurse call systems, today announced the expansion of its channel program for CarePlus™ and invites IT resellers, value added resellers (VAR) and system integrators (SI) to...


Accuray Incorporated to Speak at Oppenheimer's 21st Annual Healthcare Conference

October 26, 2010 6:33 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Oct. 26 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York City on Wednesday, November 3, 2010 at 9:40 a.m. ET/6:40 a.m....


Frost & Sullivan Award Highlights Hybridyne Technologies' Outstanding Technology Innovation

October 26, 2010 6:32 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Oct. 26 /- Based on its recent analysis of the prostate cancer diagnosis market, Frost & Sullivan recognizes Hybridyne Technologies, Inc. with the 2010 North American Frost & Sullivan Award for Technology Innovation of the Year. (Logo:  ...


Amedisys 3Q profit tumbles 40 percent

October 26, 2010 5:45 am | by The Associated Press | Comments

Amedisys Inc. said its third-quarter net income fell 40 percent, as the home health provider continued to see a volume fall-off that started in the second quarter, and it lowered the upper end of its profit forecast for 2010.The Baton Rouge, La., company said it earned $21.6 million, or 76...

IBM Analytics Helps Medical Researchers Detect Complication In Stroke Patients

October 26, 2010 5:33 am | by IBM | Comments

IBM today announced a new project in which researchers at Columbia University Medical Center will utilize IBM's streaming analytics technology to potentially detect severe complications in brain injured patients up to 48 hours earlier than traditional methods. E-mail this page Save to...

Federal Register: Risk Communication Advisory Committee; Amendment of Notice

October 26, 2010 5:30 am | by U.S. Food & Drug Administration | Comments

On November 8 and 9, 2010, the Committee will hear and discuss developments in FDA's ongoing communications programs, such as the challenges of effectively communicating with patients and caregivers about appropriate use of medical devices when...


Nugent Care installs a Kodak scanner and File Stream EDMS solution to meet statutory requirements to store care records long term

October 26, 2010 3:33 am | by RealWire | Comments

80 year storage requirement for children in care, and 6 years for adultsStorage space released and access to information requests far quickerLondon October 26, 2010 - Kodak (NYSE:EK) today announced that Nugent Care, a Merseyside-based charity operating care homes, specialist schools and...


PAREXEL Consulting Releases Annual Analysis of FDA New Drug Review Trends

October 26, 2010 3:33 am | by Bio-Medicine.Org | Comments

BOSTON, Oct. 26 /- PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL ) and a leading global life sciences consultancy serving the biopharmaceutical and medical device industries, today released a new white paper entitled Drug Innovation, Approval, Market Access,...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.